Brain Imaging Study on Biomarkers for Fibromyalgia

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

February 28, 2027

Study Completion Date

January 31, 2035

Conditions
Fibromyalgia
Interventions
DRUG

Placebos

Positive treatment expectations will be induced by giving participants capsules containing inert material and telling them that the capsules contain an effective drug that has been approved for treating Chronic Pain. They will be requested to take two capsules four times a day and report their pain on paper forms organized as a calendar or on REDCap.

Trial Locations (1)

B3h1V7

RECRUITING

Nova Scotia Health Authority, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER